[
  {
    "letter_name": "11-11-11-brands-627690-11162022",
    "violated_terms": [
      "21 U.S.C. 342(a)(2)(C)(i)",
      "21 U.S.C. 331(ll)",
      "21 U.S.C. 331(a)"
    ],
    "recommendations": [
      "Obtain premarket approval for the use of CBD in food products.",
      "Ensure proper labeling of products to disclose the presence of CBD and any potential interactions with other ingredients like caffeine.",
      "Notify FDA in writing within fifteen working days of receipt of this letter of the specific steps taken to correct these violations.",
      "Include an explanation of each step being taken to prevent the recurrence of violations, as well as copies of related documentation."
    ]
  }
]